Genome editing has been used to create potentially therapeutic transfer RNAs, which could treat multiple genetic diseases. This development may lead to disease-agnostic gene editing therapies, potentially replacing the one-gene-one-treatment model. The breakthrough has sparked discussion about the possibilities and challenges of using these therapies in humans, with some considering it a significant advancement in the field of genomic medicine.